National Amphetamine-Type Stimulant Strategy 2008-2011
References
AIDS Council of New South Wales. (2006). Crystal. http://www.acon.org.au/health/index.cfm?cat_id=103.
Australian Crime Commission. (2007). Illicit Drug Data Report 2005-06. Commonwealth of Australia.
Australian Institute of Health and Welfare. (2005). 2004 National Drug Strategy Household Survey: Detailed Findings. Canberra, AIHW cat. no. PHE 66. (Drug Statistics Series No. 16).
Australian Institute of Health and Welfare. (2006). Alcohol and other drug treatment services in Australia 2004-05: Report on the National Minimum Data Set. Drug Treatment Series no. 5. AIHW cat. no. HSE 43. Canberra: AIHW.
Allsop, S., Phillips, M., & Calogero, C. (2001). Drugs and Work. Victoria: IP Communications.
Australian National Council on Drugs. (2007). Methamphetamines: Position Paper. Commonwealth of Australia.
Baker, A., & Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist, 40 (2), 87-94.
Baker, A., Lee, N.K., & Jenner, L. (Eds). (2004). Models of intervention and care for psychostimulant users (2nd Edition). National Drug Strategy Monograph Series No. 51. Canberra: Australian Government Department of Health and Ageing.
Bywood, P., Pidd, K. & Roche, A. (2006). Information and Data Sheet 5: Illicit drugs in the Australian workforce: Prevalence and patterns of use, Workplace Drug and Alcohol Use Information and Data Series. Adelaide, South Australia: National Centre for Education and Training on Addiction, Flinders University.
Chilcoat, H. & Bresleu, N. (1999). Pathways from ADHD to early drug use. Journal of the American Academy of Child and Adolescent Psychiatry, 38 (11), 1347-1354.
Degenhardt, L., Roxburgh, A., Black, E. & Dunn, M. (2006). 2004 Cocaine and amphetamine related drug-induced deaths in Australia. Sydney: National Drug and Alcohol Research Centre.
Degenhardt, L., Roxburgh, A., & McKetin, R. (2007). Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia. Medical Journal of Australia, 186 (7), 342-345.
Department of Education, Science and Training. (2000). National Framework for Protocols for Managing the Possession, Use and/or Distribution of Illicit and Other Sanctioned Drugs in Schools. Canberra: Commonwealth Government.
Dunn, M., Degenhardt, L., Campbell, G., George, J., Johnston, J., Kinner, S., Matthews, A., Newman, J., & White, N. (2007). Australian Trends in Ecstasy and Related Drug Markets 2006: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Dyer, K.R., & Cruickshank, C.C. (2005). Depression and other psychological health problems among methamphetamine dependent patients in treatment: Implications for assessment and treatment outcome. Australian Psychologist, 40 (2), 96-108.
Homel, P., & Willis, K. (2007). A framework for measuring the performance of drug law enforcement trends and issues in crime and criminal justice. Canberra: Australian Institute of Criminology.
International Union of Pure and Applied Chemistry. (1993). A Guide to IUPAC Nomenclature of Organic Compounds. New York: Blackwell Scientific Publication.
Kalant, H. (2001). The pharmacology and toxicology of ecstasy (MDMA) and related drugs. Canadian Medical Association Journal, 165 (7), 917-928.
Kosten, T.R., Markou, A. & Koob, G.F. (1998). Depression and stimulant dependence: Neurobiology and pharmacotherapy. Journal of Nervous and Mental Disease, 186 (12), 737-745.
Lee, N., Johns, L., Jenkinson, R., Johnston, J., Connolly, K., Hall, K. & Cash, R. (2007). Clinical Treatment Guidelines for Alcohol and Drug Clinicians. No 14: Methamphetamine Dependence and Treatment. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre Inc.
Loxley, W., Toumbourou, J.W., Stockwell, T., Haines, B., Scott, K., Godfrey, C., Waters, E., Patton, G., Fordham, R., Gray, D., Marshall, J., Ryder, D., Saggers, S., Sanci, L., & Williams, J. (2004). The Prevention of Substance Use, Risk and Harm in Australia: A Review of the Evidence. Canberra: Commonwealth of Australia.
Maxwell, J.C. (2005). Emerging research on methamphetamine. Current Opinion in Psychiatry, 18, 235-242.
McIver, C., McGregor, C., Baigent, M., Spain, D., Newcombe, D., & Ali, R. (2006). Guidelines for the Medical Management of Patients With Methamphetamine-Induced Psychosis. South Australia: Drug and Alcohol Services South Australia.
McKetin, R., Kelly, E., & McLaren, J. (2006). The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence, 85, 198-204.
McKetin, R., McLaren, J. & Kelly, E. (2005). The Sydney Methamphetamine Market: Patterns supply, use personal harms and social consequences. National Drug Law Enforcement Research Fund. Monograph Series no. 13, Commonwealth of Australia.
McKetin, R., McLaren, J., Kelly, E., Hall, W., & Hickman, M. (2005). Estimating the number of regular and dependent methamphetamine users in Australia. National Drug and Alcohol Research Centre Technical Report no. 230. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Meyer, L., & Cahill, H. (2004). Principles for School Drug Education. Canberra: Australian Government Department of Education, Science and Training.
Ministerial Council on Drug Strategy Joint Communique (2007). National Leadership Forum on Ice – Compendium of Jurisdictional Achievements. http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mcds-16may07-communique
Molina, B. & Pelham, W. (2003). Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. Journal of Abnormal Psychology, 112 (3), 497-507.
Nutting, A., Lee, N.K., Jenner, L., & Davies, J. (unpublished). The prevalence of mental health disorders among clients in substance use treatment. In Drugs and Crime Prevention Committee (2004), Inquiry into Amphetamine and ‘Party Drug’ Use in Victoria: Final Report. Melbourne, Victoria: Drugs and Crime Prevention Committee.
Rothman, R.B. & Baumann, M.H. (2003). Monoamine transporters and psychostimulant drugs. European Journal of Pharmacology, 479, 23-40.
Sansom, D. (2001). Education and Training, National Hepatitis C Resource Manual (Chapter 8). Melbourne: Department of Health and Aged Care and Australian Institute of Primary Care, La Trobe University.
Spooner, C. (2005). Structural determinants of drug use – a plea for broadening our thinking. Drug and Alcohol Review, 24, 89-92.
